Monalizumab (Anti-Human CD159a)
Product Specifications
CAS Number
1228763-95-8
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Monalizumab (Anti-Human CD159a) is a novel, first-in-class humanized immunoglobulin G4 monoclonal antibody immune checkpoint inhibitor that targets the inhibitory CD94/NKG2A receptors.
Storage Conditions
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog